These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32876701)

  • 1. [Apremilast in the treatment of palmoplantar pustulosis : A case series].
    Frischhut N; Ratzinger G
    Hautarzt; 2021 Mar; 72(3):252-256. PubMed ID: 32876701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apremilast in treatment of palmoplantar pustulosis - a case series.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Int J Dermatol; 2021 Jun; 60(6):e247-e248. PubMed ID: 33475149
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Am J Clin Dermatol; 2021 May; 22(3):415-423. PubMed ID: 33712987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory palmoplantar pustulosis succesfully treated with apremilast.
    Carrascosa de Lome R; Conde Montero E; de la Cueva Dobao P
    Dermatol Ther; 2020 Mar; 33(2):e13230. PubMed ID: 31981290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.
    Bissonnette R; Pariser DM; Wasel NR; Goncalves J; Day RM; Chen R; Sebastian M
    J Am Acad Dermatol; 2016 Jul; 75(1):99-105. PubMed ID: 27021239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
    Wilsmann-Theis D; Kromer C; Gerdes S; Linker C; Magnolo N; Sabat R; Reich K; Mössner R
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2045-2050. PubMed ID: 34077577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.
    Bissonnette R; Haydey R; Rosoph LA; Lynde CW; Bukhalo M; Fowler JF; Delorme I; Gagné-Henley A; Gooderham M; Poulin Y; Barber K; Jenkin P; Landells I; Pariser DM
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):403-410. PubMed ID: 29055155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis.
    Haller C; Cozzio A; von Kempis J; Rubbert-Roth A
    J Clin Rheumatol; 2021 Oct; 27(7):e289-e290. PubMed ID: 32453211
    [No Abstract]   [Full Text] [Related]  

  • 9. Three cases of palmoplantar pustulosis successfully treated with apremilast.
    Eto A; Nakao M; Furue M
    J Dermatol; 2019 Jan; 46(1):e29-e30. PubMed ID: 29905386
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful Treatment of Palmoplantar Pustulosis With Apremilast.
    Dorgham N; Crasto D; Skopit S
    J Drugs Dermatol; 2021 Nov; 20(11):1255-1256. PubMed ID: 34784120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study.
    Kato N; Takama H; Ando Y; Yanagishita T; Ohshima Y; Ohashi W; Akiyama M; Watanabe D
    Int J Dermatol; 2021 May; 60(5):570-578. PubMed ID: 33454961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review.
    Gyldenløve M; Alinaghi F; Zachariae C; Skov L; Egeberg A
    Am J Clin Dermatol; 2022 Sep; 23(5):605-613. PubMed ID: 35737251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmoplantar pustulosis treated with oral rinse using ozone nanobubble water: A case series.
    Horiuchi Y
    Dermatol Ther; 2020 Nov; 33(6):e13924. PubMed ID: 32594645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apremilast monotherapy for palmoplantar pustulosis: Report of three cases.
    Marovt M; Marko PB
    SAGE Open Med Case Rep; 2021; 9():2050313X211034926. PubMed ID: 34394938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL.
    Stein Gold L; Bagel J; Lebwohl M; Jackson JM; Chen R; Goncalves J; Levi E; Duffin KC
    J Drugs Dermatol; 2018 Feb; 17(2):221-228. PubMed ID: 29462231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis: A Case Report.
    Del Campo DC
    J Drugs Dermatol; 2021 Oct; 20(10):1117-1119. PubMed ID: 34636515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis.
    Papadavid E; Rompoti N; Theodoropoulos K; Kokkalis G; Rigopoulos D
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1173-1179. PubMed ID: 29388335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis.
    Spencer RK; Elhage KG; Jin JQ; Davis MS; Hakimi M; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2023 Feb; 13(2):437-451. PubMed ID: 36609960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study.
    Strober B; Bagel J; Lebwohl M; Stein Gold L; Jackson JM; Chen R; Goncalves J; Levi E; Callis Duffin K
    J Drugs Dermatol; 2017 Aug; 16(8):801-808. PubMed ID: 28809995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
    Sobell JM; Foley P; Toth D; Mrowietz U; Girolomoni G; Goncalves J; Day RM; Chen R; Yosipovitch G
    Acta Derm Venereol; 2016 May; 96(4):514-20. PubMed ID: 26837052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.